• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Mimedx Group Inc (NQ: MDXG )

    7.460 -0.090 (-1.19%)
    Streaming Delayed Price Updated: 12:57 PM EDT, Jul 24, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 98,431
    Open 7.460
    Bid (Size) 7.450 (4)
    Ask (Size) 7.460 (4)
    Prev. Close 7.550
    Today's Range 7.440 - 7.570
    52wk Range 5.570 - 9.270
    Shares Outstanding 111,946,829
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Cassava Sciences Announces Changes in Executive Leadership, Enhanced Corporate Governance and Other Initiatives
    From Cassava Sciences, Inc.
    Via GlobeNewswire
    Analyst Bullish On MiMedx's Rapid Growth In $4B Woundcare Market With Innovative Skin Substitutes
    Cantor Fitzgerald has initiated coverage on MIMEDX, highlighting its strong market presence in wound care and surgical recovery. Targeting a $3.9 billion market, MIMEDX products demonstrate a 97% wound... 
    Via Benzinga

    Performance

    YTD
    -5.21%
    -5.21%
    1 Month
    +9.71%
    +9.71%
    3 Month
    +14.59%
    +14.59%
    6 Month
    -11.30%
    -11.30%
    1 Year
    N/A
    N/A

    More News

    Read More
    7 Undervalued Biotech Stocks to Buy for Big-Time Returns
    Via InvestorPlace
    MDXG Stock Earnings: MiMedx Group Beats EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    Mizuho Maintains Buy Rating for MiMedx Group: Here's What You Need To Know
    Via Benzinga
    Recap: MiMedx Group Q4 Earnings
    Via Benzinga
    MiMedx Group's Earnings: A Preview
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    Get Rich Quick With These 3 Biotech Stocks to Buy Now
    Via InvestorPlace
    ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages MiMedx Group, Inc. Investors to Inquire About Securities Class Action Investigation - MDXG
    Via NewMediaWire
    Exposures Product Safety
    MDXG LOSS ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages MiMedx Group, Inc. Investors with Losses in Excess of $100K to Inquire About Securities Class Action Investigation – MDXG
    From Rosen Law Firm
    Via Business Wire
    MIMEDX ALERT: Bragar Eagel & Squire, P.C. is Investigating MiMedx Group, Inc. on Behalf of MiMedx Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of MiMedx Group, Inc. (MDXG) on Behalf of Investors
    From Glancy Prongay & Murray LLP
    Via Business Wire
    INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of MiMedx Group, Inc. (MDXG) on Behalf of Investors
    From Law Offices of Howard G. Smith
    Via Business Wire
    The Law Offices of Frank R. Cruz Announces Investigation of MiMedx Group, Inc. (MDXG) on Behalf of Investors
    From The Law Offices of Frank R. Cruz
    Via Business Wire
    Rivian Automotive Reports Weak Delivery Figures, Joins JOYY, MiMedx Group And Other Big Stocks Moving Lower On Tuesday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Chipotle, Amazon, Deckers Outdoor, Capital One And Other Stocks Move Higher On Friday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Earnings Scheduled For October 30, 2023
    Via Benzinga
    MediWound Announces Collaboration with MIMEDX on EscharEx® Phase III Study
    From MediWound Ltd.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    MiMedx Targets Profitability with Strategic Realignment, Suspends Knee Osteoarthritis Program Activities
    Via Benzinga
    MiMedx Group (NASDAQ: MDXG) Reports Q1 2023 Financial Results Showing 21.7% Sales Growth
    Via Spotlight Growth
    Veritone, Samsara, Lexicon Pharmaceuticals And Other Big Stocks Moving Higher On Friday
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.